Beacon Financial Group Gsk PLC Transaction History

Beacon Financial Group

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 17, 2020	BUY	$42.0 - $48.25 $141,078 - $162,071	3,359 Added 42.24%	11,311 $531,000
Q3 2019 Oct 15, 2019	SELL	$40.46 - $43.52 $404 - $435	-10 Reduced 0.13%	7,952 $324,000
Q2 2019 Jul 15, 2019	SELL	$39.4 - $42.7 $1,182 - $1,281	-30 Reduced 0.38%	7,962 $319,000
Q1 2019 Apr 18, 2019	SELL	$38.57 - $42.69 $198,056 - $219,213	-5,135 Reduced 39.12%	7,992 $334,000
Q4 2018 Jan 16, 2019	SELL	$37.8 - $42.69 $233,717 - $263,952	-6,183 Reduced 32.02%	13,127 $501,000
Q3 2018 Oct 10, 2018	SELL	$39.75 - $42.69 $59,505 - $63,906	-1,497 Reduced 7.19%	19,310 $776,000
Q2 2018 Jul 11, 2018	SELL	$39.61 - $42.76 $43,650 - $47,121	-1,102 Reduced 5.03%	20,807 $839,000
Q1 2018 Apr 06, 2018	BUY	$36.18 - $40.15 $17,655 - $19,593	488 Added 2.28%	21,909 $856,000
Q4 2017 Jan 03, 2018	SELL	$35.34 - $41.9 $5.2 Million - $6.17 Million	-147,203 Reduced 87.3%	21,421 $760,000
Q3 2017 Oct 03, 2017	BUY	$39.44 - $41.55 $6.65 Million - $7.01 Million	168,624	168,624 $6.85 Million

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Beacon Financial Group, based on Form 13F filings with the SEC.

Stay updated on Beacon Financial Group with notifications on news.